If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Name, ticker change effective; 4 new contracts

6 Oct 2020 08:00

RNS Number : 2151B
Deepverge PLC
06 October 2020
 

DeepVerge plc (formerly known as Integumen)

 

Change of Name effective; ticker update

 

Four new Labskin contracts with global companies

 

6 October 2020: DeepVerge plc ("DeepVerge" or "the Company") today announces the change of name from Integumen plc to DeepVerge plc which has now been officially confirmed by the Registrar of Companies. The Ordinary Shares will trade under the name DeepVerge plc (with ticker DVRG) from 8:00 a.m. today.

 

The Company's website is now www.deepverge.com, although the www.integumen.com website will remain in operation and will redirect to the new site. All information required by AIM Rule 26 is located on the new site.

 

Ahead of the In-Cosmetics Virtual Conference[i] for ingredient suppliers today, the Company announces that Labskin has received initial orders worth c£190,000 to be completed this quarter, with four new customers, each a global player, with combined sales revenues of US$56 Billion in the cosmetics, personal care, and medical device sectors. This adds to the existing growing business of Labskin and further underpins the guided revenue of £4m for 2020.

 

Gerry Brandon, CEO, commented:

 

"The Company has changed dramatically since I joined as CEO a little over two years ago and we have not only driven the core Labskin business, now recognised as a thought leader and product development partner in the skincare world, but we have also ventured into new and important fields, with artificial intelligence services in wastewater equipment and real-time breathalyser COVID-19 products.

 

"DeepVerge reflects who we have become. A company based on Deep science in diagnostics and environmental contamination detection on the Verge of applied engineering innovation on land, sea and air. Our new name and visual identity are a signal that we are entering a new era for the Company - strong, bold and driven - connecting our core pillars of science, technology, environment and health to tackle the challenges of the future."

 

Enquires:

 

DeepVerge plc

Gerard Brandon, Chief Executive

+44 (0) 7340 055 648

 

 

 

Mo PR (Financial PR adviser)

Mo Noonan

+44 (0) 7876 444977

 

SPARK Advisory Partners Limited

Nominated Adviser

 

Neil Baldwin/Andrew Emmott

 

+44 (0) 113 370 8974

 

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / Zoe Alexander

 

+44 (0) 20 3657 0050

 

About DeepVerge plc (www.deepverge.com)

 

DeepVerge is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

 

[i] https://www.in-cosmetics.com/en/home/virtual/whats-on/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKEKESEEFEA
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.